← Leaderboards
Jose Baselga
Sloan-Kettering Inst Can Research
$1,310,766
Attributed
$1,310,766
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $436.9K · FY2015–17$500K$375K$250K$125K$0
'15
'16
'17
Funding mix
By agency
NIH$1,310,766 · 1
By mechanism
R01$1,310,766 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Charles L Sawyers$34,701,646
- Xiang Zhang$12,735,442
- Sarat Chandarlapaty$10,852,142
- David B. Solit$21,393,031
- James A Fagin$27,970,638
Others in their field
Top investigators on “Homeostasis”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$31,016,539
- John T Potts · Massachusetts General Hospital$30,823,998
- Rafick-Pierre Sekaly · University Of Montreal$27,217,321
- Elaine Fuchs · University Of Chicago$26,459,589
- Alice Telesnitsky · University Of Michigan At Ann Arbor$25,195,552
- Edward E Morrisey · University Of Pennsylvania$23,430,813
Research focus
HomeostasisImmunohistochemistryAcuteGenesAnimal TestingBreast Cancer PatientCancer CellAppearanceCellsAnimal ModelBiopsyCombinatorialDesignDigitalDisease ProgressionDna Sequence AlterationDrug ResistanceCatalytic DomainErbb2 GeneEstrogen Receptor PositiveExome SequencingBaseClinical TrialsInhibitor/Antagonist
Grant awards (3)
Unraveling resistance to PI3K-alpha inhibitors in breast cancer$436,922
R01 · FY2017 · CA · contact PI
Unraveling resistance to PI3K-alpha inhibitors in breast cancer$436,922
R01 · FY2016 · CA · contact PI
Unraveling resistance to PI3K-alpha inhibitors in breast cancer$436,922
R01 · FY2015 · CA · contact PI